The Candidiasis Market is estimated to be valued at US$ 873.8 million in 2022 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023-2030, as highlighted in a new report published by
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |